1,962
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Combined Ophthalmology and Rheumatology Evaluation in Systemic Autoimmune Diseases with Ocular Involvement: A Third Level Reference Center in Mexico

ORCID Icon, ORCID Icon, & ORCID Icon
Pages 989-995 | Received 06 Aug 2021, Accepted 13 May 2022, Published online: 27 Jun 2022

References

  • Davidson A, Diamond B. The Autoimmune Diseases. Fifth ed. Boston: Academic Press; 2014:19–37. General features of autoimmune disease.
  • McCluskey P, Powell RJ. The eye in systemic inflammatory diseases. Lancet. 2004;364(9451):2125–2133. doi:10.1016/S0140-6736(04)17554-5.
  • Generali E, Cantarini L, Selmi C. Ocular involvement in systemic autoimmune diseases. Clin Rev Allergy Immunol. 2015;49(3):263–270. doi:10.1007/s12016-015-8518-3.
  • Hamideh F, Prete PE. Ophthalmologic manifestations of rheumatic diseases. Semin Arthritis Rheum. 2001;30(4):217–241. doi:10.1053/sarh.2001.16639.
  • Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol. 1997;84(3):223–243. doi:10.1006/clin.1997.4412.
  • Brito-Zerón P, Baldini C, Bootsma H, et al. Sjögren syndrome. Nat Rev Dis Primers. 2016;2:16047. doi:10.1038/nrdp.2016.47.
  • Zeboulon N, Dougados M, Gossec L. Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature review. Ann Rheum Dis. 2008;67(7):955–959. doi:10.1136/ard.2007.075754.
  • Rosenbaum JT, Rosenzweig HL. Spondyloarthritis: the eyes have it: uveitis in patients with spondyloarthritis. Nat Rev Rheumatol. 2012;8(5):249–250. doi:10.1038/nrrheum.2012.43.
  • Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013;65(1):1–11. doi:10.1002/art.37715.
  • Kubal AA, Perez VL. Ocular manifestations of ANCA-associated vasculitis. Rheum Dis Clin North Am. 2010;36(3):573–586. doi:10.1016/j.rdc.2010.05.005.
  • Smith JR, Mackensen F, Rosenbaum JT. Therapy insight: scleritis and its relationship to systemic autoimmune disease. Nat Clin Pract Rheumatol. 2007;3:219–226.
  • Akpek EK, Thorne JE, Qazi FA, Do DV, Jabs DA. Evaluation of patients with scleritis for systemic disease. Ophthalmology. 2004;111(3):501–506. doi:10.1016/j.ophtha.2003.06.006.
  • Oray M, Meese H, Foster CS. Diagnosis and management of non-infectious immune-mediated scleritis: current status and future prospects. Expert Rev Clin Immunol. 2016;12(8):827–837. doi:10.1586/1744666X.2016.1171713.
  • Raiji VR, Palestine AG, Parver DL. Scleritis and systemic disease association in a community-based referral practice. Am J Ophthalmol. 2009;148(6):946–950. doi:10.1016/j.ajo.2009.07.021.
  • Galor A, Thorne JE. Scleritis and peripheral ulcerative keratitis. Rheum Dis Clin North Am. 2007;33(4):835–854. doi:10.1016/j.rdc.2007.08.002.
  • Diaz JD, Sobol EK, Gritz DC. Treatment and management of scleral disorders. Surv Ophthalmol. 2016;61:702–717.
  • Yagci A. Update on peripheral ulcerative keratitis. Clin Ophthalmol. 2012;6:747–754.
  • Messmer EM, Foster CS. Vasculitic peripheral ulcerative keratitis. Surv Ophthalmol. 1999;43:379–396.
  • Murray PI, Rauz S. The eye and inflammatory rheumatic diseases: the eye and rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis. Best Pract Res Clin Rheumatol. 2016;30(5):802–825. doi:10.1016/j.berh.2016.10.007.
  • Akpek EK, Uy HS, Christen W, Gurdal C, Foster CS. Severity of episcleritis and systemic disease association. Ophthalmology. 1999;106(4):729–731. doi:10.1016/S0161-6420(99)90157-4.
  • Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature (SUN) working group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140:509–516.
  • Watson PG, Hayreh SS. Scleritis and episcleritis. Br J Ophthalmol. 1976;60(3):163–191. doi:10.1136/bjo.60.3.163.
  • Lemp MA, Foulks GN. The definition and classification of dry eye disease: report of the definition and classification subcommittee of the international dry eye workshop. Ocul Surf. 2007;5(2):75–92. doi:10.1016/S1542-0124(12)70081-2.
  • Abu El-Asrar AM, Herbort CP, Tabbara KF. Retinal vasculitis. Ocul Immunol Inflamm. 2005;13(6):415–433. doi:10.1080/09273940591003828.
  • Levitt AE, McManus KT, McClellan AL, et al. Ocular inflammation in the setting of concomitant systemic autoimmune conditions in an older male population. Cornea. 2015;34(7):762–767. doi:10.1097/ICO.0000000000000437.
  • Hassan WA, Medhat BM, Youssef MM, et al. Characteristics, evolution, and outcome of patients with non-infectious uveitis referred for rheumatologic assessment and management: an Egyptian multicenter retrospective study. Clin Rheumatol. 2021;40(4):1599–1610.
  • Peláez-Ballestas I, Sanin LH, Moreno-Montoya J, et al. Epidemiology of the rheumatic diseases in Mexico. A study of 5 regions based on the COPCORD methodology. J Rheumatol Suppl. 2011;86:3–8. doi:10.3899/jrheum.100951.
  • Jiménez-Balderas FJ, Fernandez-Arrieta G, Camargo-Coronel A, et al. Uveitis in adult patients with rheumatic inflammatory autoimmune diseases at a tertiary-care hospital in Mexico city. J Rheumatol. 2011;38(2):325–330. doi:10.3899/jrheum.100015.
  • Tsirouki T, Dastiridou A, Symeonidis C, et al. A focus on the epidemiology of uveitis. Ocul Immunol Inflamm. 2018;26(1):2–16. doi:10.1080/09273948.2016.1196713.
  • Vivino FB. Sjogren’s syndrome: clinical aspects. Clin Immunol. 2017;182:48–54. doi:10.1016/j.clim.2017.04.005.
  • Maldini C, Seror R, Fain O, et al. Epidemiology of primary Sjögren’s syndrome in a French multiracial/multiethnic area. Arthritis Care Res. 2014;66(3):454–463. doi:10.1002/acr.22115.
  • Kabasakal Y, Kitapcioglu G, Turk T, et al. The prevalence of Sjögren’s syndrome in adult women. Scand J Rheumatol. 2006;35(5):379–383. doi:10.1080/03009740600759704.
  • Rothschild PR, Pagnoux C, Seror R, et al. Ophthalmologic manifestations of systemic necrotizing vasculitides at diagnosis: a retrospective study of 1286 patients and review of the literature. Semin Arthritis Rheum. 2013;42(5):507–514. doi:10.1016/j.semarthrit.2012.08.003.
  • Tugal-Tutkun I. Systemic vasculitis and the eye. Curr Opin Rheumatol. 2017;29:24–32.
  • Lin P, Bhullar SS, Tessler HH, Goldstein DA. Immunologic markers as potential predictors of systemic autoimmune disease in patients with idiopathic scleritis. Am J Ophthalmol. 2008;145:3. doi:10.1016/j.ajo.2007.09.024.
  • Rudwaleit M, van der Heijde D, Landewe R, Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, et al. The development of assessment of SpondyloArthritis international society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68(6):777–783. doi:10.1136/ard.2009.108233.
  • Agarwal A, Karkhur S, Aggarwal K, et al. Epidemiology and clinical features of inflammatory retinal vascular occlusions: pooled data from two tertiary-referral institutions. Clin Exp Ophthalmol. 2018;46(1):62–74.
  • De la Mora A, Aurrecoechea E, Del Corral AD, Calvo J. Rheumatology-ophthalmology collaborative uveitis units may improve the diagnostic and therapeutic approach of this pathology: experience from a uveitis unit in a secondary spanish hospital. J Arthritis. 2016;5(5):1–3. doi:10.4172/2167-7921.1000215.
  • Fanlo P, Espinosa G, Adan A, et al. Multidisciplinary care and units for uveitis in the internal medicine departments in Spain: survey of the systemic autoimmune diseases group. Rev Clín Esp. 2021;221(4):221–225. doi:10.1016/j.rce.2019.11.018.
  • Tseng ST, Yao TC, Huang JL, Yeh KW, Hwang YS. Clinical manifestations in uveitis patients with and without rheumatic disease in a Chinese population in Taiwan. J Microbiol Immunol Infect. 2017;50(6):798–804. doi:10.1016/j.jmii.2015.10.007.
  • Hart CT, Zhu EY, Crock C, Rogers SL, Lim LL. Epidemiology of uveitis in urban Australia. Clin Exp Ophthalmol. 2019;47:733–740.
  • Bajwa A, Osmanzada D, Osmanzada S, et al. Epidemiology of uveitis in the mid-atlantic United States. Clin Ophthalmol. 2015;9:889–901.
  • Cimino L, Aldigeri R, Salvarani C, et al. The causes of uveitis in a referral centre of northern Italy. Int Ophthalmol. 2010;30(5):521–529.
  • Bertrand PJ, Jamilloux Y, Ecochard R, et al. Uveitis: autoimmunity … and beyond. Autoimmun Rev. 2019;18(9):102351. doi:10.1016/j.autrev.2019.102351.
  • Uribe-Reina P, Muñoz-Ortiz J, Cifuentes-González C, et al. Ocular manifestations in colombian patients with systemic rheumatologic diseases. Clin Ophthalmol. 2021;15:2787–2802.
  • de-la-Torre A, López-Castillo CA, Rueda JC, et al. Clinical patterns of uveitis in two ophthalmology centres in Bogota, Colombia. Clin Exp Ophthalmol. 2009;37(5):458–466. doi:10.1111/j.1442-9071.2009.02082.x.
  • Talat L, Lightman S, Tomkins-Netzer O. Ischemic retinal vasculitis and its management. J Ophthalmol. 2014;2014:197675. doi:10.1155/2014/197675.
  • Soto-Vega E, García-Muñoz R, Richaud-Patin Y, et al. Class I and class II MHC polymorphisms in Mexican patients with Behçet’s disease. Immunol Lett. 2004;93:211–215. doi:10.1016/j.imlet.2004.03.017.
  • Leal I, Romão VC, Mano S, et al. A non-infectious uveitis multidisciplinary clinic in a tertiary referral center: clinical impact and added value. J Multidiscip Healthc. 2021;14:695–704. doi:10.2147/JMDH.S292981.
  • Hysa E, Cutolo CA, Gotelli E, et al. Immunopathophysiology and clinical impact of uveitis in inflammatory rheumatic diseases: an update. Eur J Clin Invest. 2021;51(8):e13572. doi:10.1111/eci.13572.